Accenture, BioCelerate Collaborate on Preclinical Platform

Article

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information in the hopes of improving drug development efficiency.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.